Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06052371Terminated

Project VerioVue Enhancements - Neonate Study

Role: lead

NCT06121856Completed

Project VerioVue Enhancements - Arterial Study

Role: lead

NCT03638349Completed

Actions & Insights Evaluating a Novel Diabetes Management Solution

Role: lead

NCT03515421Not ApplicableCompleted

Project Frazier 3 Regulatory Clinical Evaluation

Role: lead

NCT04262700Not ApplicableUnknown

Customer Outcomes & Value Experiencing A New Monitoring Technology

Role: lead

NCT03920085Not ApplicableCompleted

Clinical Evaluation of LifeScan Blood Glucose Monitoring Systems

Role: lead

NCT03851549Not ApplicableUnknown

A User Performance and System Use Evaluation of a New Blood Glucose Monitoring System ( BGMS)

Role: lead

All 7 trials loaded